Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2005
06/30/2005CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof
06/30/2005CA2549589A1 Prolinylarylacetamides
06/30/2005CA2549167A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease
06/30/2005CA2549098A1 Hiv protease inhibiting compounds
06/30/2005CA2548793A1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
06/30/2005CA2548657A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
06/30/2005CA2548571A1 Diacylhydrazine derivatives
06/30/2005CA2548393A1 Chemokine receptor binding compounds
06/30/2005CA2548388A1 Heterocyclic aspartyl protease inhibitors
06/30/2005CA2548273A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
06/30/2005CA2547600A1 Novel herbicides
06/30/2005CA2547518A1 Quinolines useful in treating cardiovascular disease
06/30/2005CA2546260A1 Regiospecific synthesis of nicotine derivatives
06/30/2005CA2545294A1 Tetronic and tetramic acids as inhibitors of beta-secrease
06/30/2005CA2543076A1 Crystalline forms of (+)- and (-)-erythro-mefloquine hydrochloride
06/29/2005EP1548015A1 Novel crystals
06/29/2005EP1548008A1 Compound having tgf-beta inhibitory activity and medicinal composition containing the same
06/29/2005EP1548007A1 2-Pyridinylethylcarboxamide derivatives and their use as fungicides
06/29/2005EP1548005A1 Process for producing 2-substituted pyridine derivative
06/29/2005EP1547616A1 Preventive and/or therapeutic drugs for itch
06/29/2005EP1546158A1 Azole derivatives as antifungal agents
06/29/2005EP1546145A1 Heterocyclic substituted piperazines for the treatment of schizophrenia
06/29/2005EP1546143A1 Heterocyclic substituted piperazines for the treatment of schizophrenia
06/29/2005EP1546133A2 N-substitute-2-oxodihydropyridine derivatives as npy antagonists
06/29/2005EP1546132A1 Pyrazole derivatives as reverse transcriptase inhibitors
06/29/2005EP1546131A1 Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
06/29/2005EP1546130A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states
06/29/2005EP1546128A1 Pyrimidine derivatives as selective cox-2 inhibitors
06/29/2005EP1546127A1 Novel pyrimidineamide derivatives and the use thereof
06/29/2005EP1546121A1 Substituted triazine kinase inhibitors
06/29/2005EP1546117A2 Protein kinase inhibitors and uses thereof
06/29/2005EP1546116A1 Vanilloid receptor ligands and their use in treatments
06/29/2005EP1546115A2 Substituted pyrimidines
06/29/2005EP1546113A1 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
06/29/2005EP1546111A2 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
06/29/2005EP1546109A2 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
06/29/2005EP1546101A1 Naphthyl ether compounds and their use
06/29/2005EP1546100A1 New benzoyl piperidine compounds
06/29/2005EP1546099A2 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists
06/29/2005EP1546097A1 Pyrrole derivatives as antimycobacterial compounds
06/29/2005EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation
06/29/2005EP1545543A2 Novel tyrosine kinases inhibitors
06/29/2005EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives
06/29/2005EP1545530A1 Novel crystalline forms of gatifloxacin
06/29/2005EP1545529A2 Novel tyrosine kinase inhibitors
06/29/2005EP1545528A2 Indole-type derivatives as inhibitors of p38 kinase
06/29/2005EP1545527A1 Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor
06/29/2005EP1545525A2 Radiolabeled neurokinin-1 receptor antagonists
06/29/2005EP1545524A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity.
06/29/2005EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS
06/29/2005EP1545515A1 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
06/29/2005EP1545513A2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
06/29/2005EP1545483A2 Non-nucleoside reverse transcriptase inhibitors
06/29/2005EP1432686B1 Tetrahydroisochinolines, their production and the use thereof as analgesics
06/29/2005EP1274701B1 [1,4']-bipiperidine compounds
06/29/2005CN1633433A N-aroyl cyclic amines
06/29/2005CN1633431A 喹唑啉衍生物类激酶抑制剂 Quinazoline derivatives kinase inhibitors
06/29/2005CN1633430A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
06/29/2005CN1633429A 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
06/29/2005CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
06/29/2005CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
06/29/2005CN1633418A Arylalkane-sulfonamides having endothelin-antagonist activity
06/29/2005CN1633417A Imidazolone derivatives for the treatment of viral diseases
06/29/2005CN1633416A Nicotinamide derivates useful as p38 inhibitors
06/29/2005CN1633414A Chemical compounds
06/29/2005CN1633413A 20-hydroxyeicosatetraenoic acid production inhibitors
06/29/2005CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
06/29/2005CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists
06/29/2005CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/29/2005CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
06/29/2005CN1633289A Hemiasterlin derivatives and uses thereof
06/29/2005CN1631887A Nitryl methylene derivatives and uses thereof
06/29/2005CN1208342C [2-[5-(2-chloropyridineoxy)]methyl] azacyclobutane polypeptide derivative and its application
06/29/2005CN1208333C Indole derivatives useful for the treatment of osteoporosis
06/29/2005CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/29/2005CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
06/29/2005CN1208318C Cycloamine CCR5 receptor antagonists
06/28/2005US6911677 Light sources comprising organic light emmiters between electrodes, used in displaying, electrophotography, recording, exposure, signs or optical communications; brightness; efficiency; durability
06/28/2005US6911595 Charge transfer material, and photoelectric conversion device and photoelectric cell using same, and pyridine compound
06/28/2005US6911535 Biomolecule/polymer conjugates
06/28/2005US6911467 Useful for the treatment of type 2 diabetes, impaired glucose tolerance and certain other conditions
06/28/2005US6911465 For treating inflammatory diseases including rheumatoid arthritis, glomerular nephritides, lung fibrosis, restenosis, alveolitis, asthma, psoriasis, inflammatory bowel disease, multiple sclerosis and brain trauma, stroke, ischemia
06/28/2005US6911463 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity
06/28/2005US6911462 Benzimidazole compounds for regulating IgE
06/28/2005US6911461 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse
06/28/2005US6911458 Compounds
06/28/2005US6911453 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
06/28/2005US6911447 Non-aromatic carbocyclic rings; aromatic carbocyclic rings; non-aromatic heterocyclic rings; aromatic heterocyclic rings; compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4
06/28/2005US6911442 Has no toxicological effects; adapted for oral, topical or parenteral use and may be used for the treatment of bacterial infection in mammals
06/28/2005US6911440 For the treatment of inflammatory rheumatic/rheumatoid diseases and/or pain, rheumatoid arthritis
06/28/2005US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
06/28/2005CA2159071C 4-arylisoindole analgesics
06/23/2005WO2005056550A2 Heterocyclic anti-migraine agents
06/23/2005WO2005056547A2 Quinoxalines useful as inhibitors of protein kinases
06/23/2005WO2005056546A1 Keto lactam compounds and use thereof
06/23/2005WO2005056535A1 1,2,3-triazole amide derivatives as inhibitors of cytokine production
06/23/2005WO2005056533A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
06/23/2005WO2005056528A1 Carboxamide derivatives
06/23/2005WO2005056520A1 Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
06/23/2005WO2005056508A1 Method for the production of tetrahydrogeranylacetone
1 ... 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 ... 1080